{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:18:14Z","timestamp":1792293494307,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013741","name":"Royal Australian and New Zealand College of Radiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013026","name":"Hunter Cancer Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.radonc.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T17:25:45Z","timestamp":1573233945000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-5383","authenticated-orcid":false,"given":"Michael","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-5506","authenticated-orcid":false,"given":"Catherine","family":"Coolens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-0393","authenticated-orcid":false,"given":"Peter","family":"Stanwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Capp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Sridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameen","family":"Arm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Holder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Oldmeadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.10.001_b0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2019.10.001_b0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.radonc.2019.10.001_b0015","first-page":"1","article-title":"Implementing Intensity-modulated radiotherapy with simultaneous integrated boost for anal cancer: 3 year outcomes at two Sydney Institutions","author":"Yates","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0025","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1016\/j.ijrobp.2016.06.1006","article-title":"The development of an umbrella trial (PLATO) to address radiation therapy dose questions in the locoregional management of squamous cell carcinoma of the anus","volume":"96","author":"Sebag-Montefiore","year":"2016","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.radonc.2019.10.001_b0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"111","author":"Glynne-Jones","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2009.08.055","article-title":"Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome?","volume":"78","author":"Goh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0040","first-page":"1","article-title":"The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer","volume":"27","author":"Kochhar","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2019.10.001_b0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ijrobp.2008.08.023","article-title":"Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer","volume":"74","author":"Zahra","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0050","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1078-0432.CCR-08-1287","article-title":"Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck","volume":"15","author":"Kim","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.10.001_b0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2011.07.017","article-title":"Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy","volume":"83","author":"Barbaro","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0060","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2010.12.063","article-title":"Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results","volume":"82","author":"Lambrecht","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0065","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00330-012-2496-0","article-title":"Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation","volume":"22","author":"Somoye","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2019.10.001_b0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2016.05.009","article-title":"Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy","volume":"120","author":"Heethuis","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijrobp.2018.03.028","article-title":"Emerging magnetic resonance imaging technologies for radiation therapy planning and response assessment","volume":"101","author":"Jones","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.clon.2018.08.003","article-title":"MRI-linear accelerator radiotherapy systems","volume":"30","author":"Liney","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2019.10.001_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12885-015-1244-7","article-title":"Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy","volume":"15","author":"Jones","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2019.10.001_b0090","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.radonc.2019.10.001_b0095","first-page":"20170461","article-title":"Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer","author":"Coolens","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2019.10.001_b0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.18383\/j.tom.2016.00178","article-title":"Comparison of voxel-wise tumor perfusion changes measured with dynamic contrast-enhanced (DCE) MRI and volumetric DCE CT in patients with metastatic brain cancer treated with radiosurgery","volume":"2","author":"Coolens","year":"2016","journal-title":"Tomography"},{"key":"10.1016\/j.radonc.2019.10.001_b0105","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","article-title":"The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis","volume":"22","author":"Jones","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2019.10.001_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.adro.2017.04.007","article-title":"Quantitative FDG-PET\/CT predicts local recurrence and survival for squamous cell carcinoma of the anus","volume":"2","author":"Cardenas","year":"2017","journal-title":"Adv Radiat Oncol."},{"key":"10.1016\/j.radonc.2019.10.001_b0115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1593\/tlo.13532","article-title":"Diffusion-weighted MRI as a biomarker of tumor radiation treatment response heterogeneity: a comparative study of whole-volume histogram analysis versus voxel-based functional diffusion map analysis","volume":"6","author":"Lemasson","year":"2013","journal-title":"Transl Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2214\/AJR.12.9926","article-title":"Histogram-based apparent diffusion coefficient analysis: an emerging tool for cervical cancer characterization?","volume":"200","author":"Rosenkrantz","year":"2013","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.radonc.2019.10.001_b0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","article-title":"Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?","volume":"3","author":"Davnall","year":"2012","journal-title":"Insights Imaging"},{"key":"10.1016\/j.radonc.2019.10.001_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/bjc.2011.191","article-title":"DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6","volume":"105","author":"O'Connor","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2019.10.001_b0135","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1088\/0031-9155\/56\/6\/006","article-title":"Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?","volume":"56","author":"Alic","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2019.10.001_b0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1756-9966-28-87","article-title":"Non-Hodgkin lymphoma response evaluation with MRI texture classification","volume":"28","author":"Harrison","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.10.001_b0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.11110264","article-title":"Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker","volume":"261","author":"Goh","year":"2011","journal-title":"Ry"},{"key":"10.1016\/j.radonc.2019.10.001_b0150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.12120167","article-title":"Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted mr imaging for the prediction of treatment response","volume":"266","author":"King","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2019.10.001_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-016-0715-6","article-title":"Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo- radiotherapy","volume":"11","author":"Meng","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1118\/1.4937791","article-title":"Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma","volume":"43","author":"Tyagi","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00330-017-5284-z","article-title":"Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy","volume":"28","author":"Hocquelet","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2019.10.001_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2019.01.022","article-title":"MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer","volume":"134","author":"Owczarczyk","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0175","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2019.10.001_b0180","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18383\/j.tom.2018.00048","article-title":"Accuracy and performance of functional parameter estimation using a novel numerical optimization approach for GPU-based kinetic compartmental modeling","volume":"5","author":"Svistoun","year":"2019","journal-title":"Tomography"},{"key":"10.1016\/j.radonc.2019.10.001_b0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(06)71012-9","article-title":"Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy","volume":"8","author":"Zahra","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2019.10.001_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijrobp.2013.05.026","article-title":"Increasing the accuracy of volume and ADC delineation for heterogeneous tumor on diffusion-weighted MRI: correlation with PET\/CT","volume":"87","author":"Gong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2014.09.028","article-title":"Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers","volume":"91","author":"Coolens","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.10.001_b0205","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archsurg.135.9.1090","article-title":"Patterns of recurrence in anal canal carcinoma","volume":"9","author":"Faynsod","year":"2000","journal-title":"Arch Surg"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019331184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019331184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:08:00Z","timestamp":1759122480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019331184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":41,"alternative-id":["S0167814019331184"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.10.001","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}